Загрузка...
Targets for therapy in sarcomeric cardiomyopathies
To date, no compounds or interventions exist that treat or prevent sarcomeric cardiomyopathies. Established therapies currently improve the outcome, but novel therapies may be able to more fundamentally affect the disease process and course. Investigations of the pathomechanisms are generating molec...
Сохранить в:
| Опубликовано в: : | Cardiovasc Res |
|---|---|
| Главные авторы: | , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Oxford University Press
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4402369/ https://ncbi.nlm.nih.gov/pubmed/25634554 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cvr/cvv023 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|